M C Fung1, D L Bowen. 1. Center of Drug Evaluation and Research, Food and Drug Administration, Rockville, Maryland, USA.
Abstract
BACKGROUND: Legitimate medicinal use of silver-containing products has dramatically diminished over the last several decades. Recently, however, some manufacturers have begun to enthusiastically promote oral colloidal silver proteins as mineral supplements and for prevention and treatment of many diseases. Indiscriminate use of silver products can lead to toxicity such as argyria. OBJECTIVE: To assist health care professionals in a risk versus benefit assessment of over-the-counter silver-containing products, we herein examine the following issues: historical uses, chemistry, pharmacology, clinical toxicology, case reports of adverse events in the literature, and the recent promotion of over-the-counter silver products. Other sources of silver exposure (including environmental and dietary) and EPA exposure standards are discussed. A list of currently available silver products is provided for easy reference and screening. CONCLUSIONS: We emphasize the lack of established effectiveness and potential toxicity of these products.
BACKGROUND: Legitimate medicinal use of silver-containing products has dramatically diminished over the last several decades. Recently, however, some manufacturers have begun to enthusiastically promote oral colloidal silver proteins as mineral supplements and for prevention and treatment of many diseases. Indiscriminate use of silver products can lead to toxicity such as argyria. OBJECTIVE: To assist health care professionals in a risk versus benefit assessment of over-the-counter silver-containing products, we herein examine the following issues: historical uses, chemistry, pharmacology, clinical toxicology, case reports of adverse events in the literature, and the recent promotion of over-the-counter silver products. Other sources of silver exposure (including environmental and dietary) and EPA exposure standards are discussed. A list of currently available silver products is provided for easy reference and screening. CONCLUSIONS: We emphasize the lack of established effectiveness and potential toxicity of these products.
Authors: Hyok Bu Kwon; Joon Ho Lee; Seung Ho Lee; Ai Young Lee; Jong Sun Choi; Yeon Soon Ahn Journal: Ann Dermatol Date: 2009-08-31 Impact factor: 1.444
Authors: Kim R Rogers; Taylor E Henson; Jana Navratilova; Mark Surette; Michael F Hughes; Karen D Bradham; Aleksandr B Stefaniak; Alycia K Knepp; Lauren Bowers Journal: Sci Total Environ Date: 2020-04-14 Impact factor: 7.963
Authors: Rolf B Saager; Khaled M Hassan; Clement Kondru; Anthony J Durkin; Kristen M Kelly Journal: Lasers Surg Med Date: 2013-01-15 Impact factor: 4.025